SKINVISIBLE, INC.

Skinvisible, Inc. is a pharmaceutical research and development company that develops polymer delivery systems and topical formulations. Operating through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., the company focuses on its patented polymer delivery system, Invisicare, which bonds active ingredients to the skin without alcohol, silicones, waxes, or organic solvents. Skinvisible formulates topical prescription and over-the-counter products, which it out-licenses globally to pharmaceutical and consumer goods manufacturers and marketers. It also provides formulation co-development and life cycle management services for products coming off patent. Its formulations target dermatology and skincare markets as well as transdermal applications for conditions such as obesity and diabetes.

The company operates from its principal executive offices located in Las Vegas, Nevada. Its proprietary Invisicare technology and associated product formulations are licensed internationally across approximately sixty countries. Products are manufactured on a purchase order basis by three third-party manufacturing facilities. The company operates with two employees, including its chief executive officer.

Summary of the business section of Skinvisible's latest annual report, written by StockData.

“Currently, we have two employees, including our Director and CEO Terry Howlett.”